Effects of HELP therapy on acute ischemic stroke and vascular endothelial cell function

Therapeutic Apheresis and Dialysis

Volumn 11, Issue 3, 2007, Pages 171-176

  Xue, Jun ^a   Dong, Qiang ^a   Han, Xiang ^a   You, Huaizhou ^a   Gu, Yong ^a   Lin, Shanyan ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

Acute ischemic stroke; Endothelial dysfunction; HELP system

Indexed keywords

ACETYLSALICYLIC ACID; APOLIPOPROTEIN A; C REACTIVE PROTEIN; CELL ADHESION MOLECULE; DEXTRAN; FIBRINOGEN; HEPARIN; LOW DENSITY LIPOPROTEIN; MONOCYTE CHEMOTACTIC PROTEIN; OXIDIZED LOW DENSITY LIPOPROTEIN; SALVIA MILTIORRHIZA EXTRACT; STATIN; THROMBOMODULIN;

ADULT; AGED; ARTICLE; BLOOD RHEOLOGY; BRAIN INFARCTION; CELL CULTURE; CELL FUNCTION; CELL MEMBRANE PERMEABILITY; CEREBROVASCULAR ACCIDENT; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; CORRELATION COEFFICIENT; DAILY LIFE ACTIVITY; ENDOTHELIAL DYSFUNCTION; ENDOTHELIUM CELL; FEMALE; HOSPITALIZATION; HUMAN; LIPID BLOOD LEVEL; MALE; PRIORITY JOURNAL; PROGNOSIS; UMBILICAL VEIN; VASCULAR ENDOTHELIUM;

ACUTE DISEASE; AGED; CEREBROVASCULAR ACCIDENT; ENDOTHELIAL CELLS; FEMALE; FIBRINOGEN; HEPARIN; HUMANS; LIPOPROTEINS, LDL; MALE; MIDDLE AGED; PRECIPITATION;

EID: 34248211725     PISSN: 17449979     EISSN: 17449987     Source Type: Journal    
DOI: 10.1111/j.1744-9987.2007.00467.x     Document Type: Article

References (17)

1. Generalized efficacy of t-PA for acute stroke. Subgroup analysis of the NINDS t-PA Stroke Trial. Stroke 1997 28 : 2119 25.
2. Jaeger BR. The HELP system for the treatment of atherothrombotic disorders: a review. Ther Apher Dial 2003 7 : 391 6.
3. Suckfull M, Seidel D, Thiery J et al. [Treatment of sudden hearing loss through Fibrinogen/LDL-apheresis. A prospective, randomized multicenter trial]. Z Kardiol 2003 92 : III59 III63.
4. Morozumi J, Mishima S, Ohta S et al. The role of edaravone on the impairment of endothelial barrier function induce by acute oxidative stress in cultured human umbilical vein endothelial cell monolayer. J Trauma 2005 59 : 570 4.
5. Ernst E. Plasma fibrinogen - an independent cardiovascular risk factor. J Intern Med 1990 227 : 365 72.
6. Jaeger BR, Labarrere CA. [Fibrinogen and atherothrombosis: vulnerable plaque or vulnerable patient?] Herz 2003 28 : 530 8.
7. Meschia JF. Anticoagulant and defibrinogenating agents in acute ischemic stroke and cerebral venous thrombosis. Semin Neurol 1998 18 : 461 70.
8. Sherman DG, Atkinson RP, Chippendale T et al. Intravenous ancrod for treatment of acute ischemic stroke: the STAT study: a randomized controlled trial. Stroke Treatment with Ancrod Trial. JAMA 2000 283 : 2395 403.
9. Samsa GP, Matchar DB, Williams GR, Levy DE. Cost-effectiveness of ancrod treatment of acute ischaemic stroke: results from the Stroke Treatment with Ancrod Trial (STAT). J Eval Clin Pract 2002 8 : 61 70.
10. Walzl M, Schied G, Walzl B. Effects of ameliorated haemorheology on clinical symptoms in cerebrovascular disease. Atherosclerosis 1998 139 : 385 9.
11. Walzl B, Walzl M, Valetitsch H, Lechner H. Increased cerebral perfusion following reduction of fibrinogen and lipid fractions. Haemostasis 1995 25 : 137 43.
12. Ridker PM. Cardiology patient page. C-reactive protein: a simple test to help predict risk of heart attack and stroke. Circulation 2003 108 : e81 e5.
13. Jaeger BR, Goehring P, Schirmer J et al. Consistent lowering of clotting factors for the treatment of acute cardiovascular syndromes and hypercoagulability: a different patho physiological approach. Ther Apher 2001 5 : 252 9.
14. Wurzner R, Schuff-Werner P, Franzke A et al. Complement activation and depletion during LDL-apheresis by heparin-induced extracorporeal LDL-precipitation (HELP). Eur J Clin Invest 1991 21 : 288 94.
15. Schettler V, Methe H, Schuff-Werner P et al. Acute effect of HELP treatment on radical scavenging enzyme activities, total glutathione concentrations in granulocytes, and selenium in plasma. Eur J Clin Invest 2000 30 : 26 32.
16. Bosch T. Recent advances in therapeutic apheresis. J Artif Organs 2003 6 : 1 8.
17. Mellwig KP, Baller D, Glerchmann U et al. Improvement of coronary vasodilation capacity through single LDL-apheresis. Atherosclerosis 1998 139 : 173 8.